Continuous subcutaneous insulin infusion (CSII) in diabetic pregnancy: A review

Recent Patents on Endocrine, Metabolic and Immune Drug Discovery

Volumn 3, Issue 2, 2009, Pages 150-153

  Napoli, Angela ^a   Festa, Camilla ^a   Dongiovanni, Marzia ^a   Mattei, Luca ^a   Colatrella, Antonietta ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

CSII; Pregnancy

Indexed keywords

INSULIN;

CLINICAL TRIAL; CONTINUOUS INFUSION; DIET; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GLYCEMIC CONTROL; HEALTH CARE COST; HUMAN; INSULIN PUMP; LIFESTYLE; MATERNAL DIABETES MELLITUS; MICROALBUMINURIA; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME;

EID: 70349249777     PISSN: 18722148     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221409788452327     Document Type: Review

References (33)

1. American Diabetes Association. Executive Summary: Standards of medical care in diabetes. Diabetes Care 2008; 31(Suppl1): S5-S11.
2. The Diabetes Control And Complications Research Group (DCCT Group). Pregnancy outcomes in the diabetes control and complications trial. Am J Obstet Gynecol 1996; 174: 1343-1353.
3. American Diabetes Association. Standards of medical care in Diabetes. Diabetes Care 2007; 30(Suppl1): S4-S41.
4. Pregnancy and Neonatal Care Subgroup to the St Vincent Joint Task Force for Diabetes. Report, British Diabetic Association 1994.
5. Casson IF, Clarke CA, Howard CV, et al. Outcome of pregnancy in insulin dependent diabetic women: Results of a five year population cohort study. BMJ 1997; 315: 275-278.
6. Diabetes and Pregnancy Group, France. French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 2003; 26: 2990-2993.
7. Jensen DM, Damm P, Moelsted-Pedersen L, et al. Outcomes in type 1 diabetic pregnancies: A nationwide, population-based study. Diabetes Care 2004; 27: 2819-2823.
8. Lapolla A, Dalfrà MG, Di Cianni G, Bonomo M, Parretti E, Mello G. Scientific Committee of the Gisogd Group. A multicenter Italian study on pregnancy outcome in women with diabetes. Nutr Metab Cradiovasc Dis 2008; 18(4): 291-297.
9. Bruttomesso D, Costa S, Crazzolara D, Di Bartolo P, Girelli A, Tiengo A, The Italian Study Group on Diffusion of CSII. Continuous subcutaneous insulin infusion (CSII) in Italy. Diabetes Res Clin Pract 2006; 74: S130-S134.
10. Murphy HR, Rayman G, Temple RC. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: Randomized clinical trial. BMJ 2008; 337: a1680.
11. Lenhard MJ, Reeves GD. Continuous subcutaneous insulin infusion: A comprehensive review of insulin pump therapy. Arch Intern Med 2001; 161: 2293-2300.
12. Nielsen LR, Pedersen-Bjergaard TB, Johansen M, Damm P, Mathiesen ER. Hypoglycemia in pregnant women with type 1 diabetes: Predictors and role of metabolic control. Diabetes Care 2008;31: 9-14.
13. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years. Evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002; 25: 593-598.
14. Gabbe SG. New concepts and applications in the use of the insulin pump during pregnancy. J Matern Fetal Neonatal Med 2000; 9: 42-45.
15. Takahashi D, Xiao Y, Hu F, et al. Guidance on the use of the continuous subcutaneous insulin infusion for diabetes. National Institute for Clinical Excellence. Technol Appraisal 2008; 151: AL 35487-0290.
16. American Diabetes Association. Continuous subcutaneous insulin infusion. Diabetes Care 2004; 27 (Suppl 1): S110.
17. Lee, H.-K., Kim, H.-C.: US2008208173A1 (2008).
18. Coustan DR, Reece EA, Sherwin RS, et al. A randomized clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancies. JAMA 1986; 255: 631-636.
19. Burkart W, Hanker JP, Schneider HP. Complications and fetal outcome in diabetic pregnancy. Intensified conventional versus insulin pump therapy. Gynecol Obstet Invest 1988; 26: 104-112.
20. Carta Q, Meriggi E, Trossarelli GF, et al. Continuous subcutaneous insulin infusion versus intensive conventional insulin therapy in type I and type II diabetic pregnancy. Diabete Metab 1986; 12: 121-129.
21. Nosari I, Maglio ML, Lepore G, et al. Is continuous subcutaneous insulin infusion more effective than intensive conventional insulin therapy in the treatment of pregnant diabetic women? Diabetes Nutr Metab 1993; 6: 33-37.
22. Farrar D, Tuffnell DJ, West J. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst Rev 2007; 3: CD00554.
23. Mukhopadhyay A, Farrell T, Fraser RB, et al. Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: A systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol 2007; 197: 447-456.
24. Hiéronimus S, Cupelli C, Bongain A, et al. Pregnancy in type 1 diabetes: Insulin pump versus intensified conventional therapy. Gynecol Obstet Fertil 2005; 33: 389-394.
25. Chen R, Ben-Harosuh A, Weissman-Brenner A, Melamed N, Hod M, Yogev Y. Level of glycemic control and pregnancy outcome in type 1 diabetes: A comparison between multiple daily insulin injections and continuous subcutaneous insulin infusions. Am J Obstet Gynecol 2007; 197: 404e1-404e5.
26. Giménez M, Conget I, Nicolau J, et al. Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study. Acta Diabetol 2007; 44: 34-37.
27. Cypryk K, Kosiński M, Kamińska P, et al. Diabetes control and pregnancy outcomes in women with type 1 diabetes treated during pregnancy with continuous subcutaneous insulin infusion or multiple daily insulin injections. Pol Arch Med Wewn 2008; 118(6): 339-344.
28. Lapolla A, Dalfrà MG, Masin M, et al. Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy. Acta Diabetol 2003; 40: 143-149.
29. Kernaghan D, Farrell T, Hammond P, et al. Fetal growth in women managed with insulin pump therapy compared to conventional insulin. Eur J Obstet Gynecol Reprod Biol 2008; 137: (1): 47-49.
30. Simmons D, Thompson CF, Conroy C, et al. Use of insulin pumps in pregnancies complicated by type 2 diabetes and gestational diabetes in a multiethnic community. Diabetes Care 2001; 24: 2078-2082.
31. Steil, G.M., Kanderian, S.S.J., Cantwell, M.T., Hoss, U.: WO2008094249A1 (2008).
32. Uchino, H., Tanaka, Y., Kawamori, R.: US2008119826A1 (2008).
33. Gabbe SG, Holling E, Temple P, Brown ZA. Benefits, risks, costs and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus. Am J Obstet Gynecol 2000; 182: 1283-1291.